Dr Reddys Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Dr Reddys Laboratories Ltd are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 18, 2019 and ending today September 16, 2019. Click here to learn more.
USD 0.44  1.15%

Dr Reddys Summary

Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people. The company currently falls under 'Mid-Cap' category with total capitalization of 6.07B. Dr Reddys Laboratories runs under Healthcare sector within Drug Manufacturers - Specialty & Generic industry. The entity has 165.72M outstanding shares of which 1.68M shares are at this time shorted by investors with about 7.68 days to cover shorted positions. DR. REDDY'S LAB L has about 283.41M in cash with 75.58M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Check Dr Reddys Probability Of Bankruptcy

Ownership Allocation (%)

Dr Reddys Target Price Odds Analysis

Odds Below 38.78HorizonTargetOdds Above 38.78
68.23%30 days 38.78 31.69%
Based on normal probability distribution, the odds of Dr Reddys to move above current price in 30 days from now is about 31.69% (This Dr Reddys Laboratories Ltd probability density function shows the probability of Dr Reddys Stock to fall within a particular range of prices over 30 days) .

Dr Reddys Laboratories Top Holders

Dr Reddys Laboratories Risk Profiles

Dr Reddys Key Fundamentals

Dr Reddys Against Markets

Dr Reddys Vital Trading Data

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people. more
NameDr Reddys Laboratories Ltd
Thematic Classification
Currently Active Investing Idea
View All
Analyst Consensus
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
Business Address8-2-337, Road No. 3
ExchangeBATS Exchange
IndustryDrug Manufacturers - Specialty & Generic
Phone91 40 4900 2900
CurrencyUSD - US Dollar
Next Fiscal Year EndMarch 31, 2021
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndMarch 31, 2019
Date Short InterestAugust 15, 2019

Dr Reddys Distributions to stockholders

Dr Reddys Corporate Directors

Hans Hasler Additional Independent Director
Leo Puri Non-Executive Independent Director
Ravi Bhoothalingam Non-Executive Independent Director
Additionally take a look at Your Equity Center. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Search macroaxis.com